| Smile Dental Centralia Llc | |
|
110 W Sneed St Centralia MO 65240-1375 | |
| (573) 682-5616 | |
| Not Available |
| Full Name | Smile Dental Centralia Llc |
|---|---|
| Speciality | Dentist - General Practice |
| Location | 110 W Sneed St, Centralia, Missouri |
| Authorized Official Name and Position | Debbie Sue Powell (OFFICE MANAGER) |
| Authorized Official Contact | 6602636642 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Smile Dental Centralia Llc Po Box 306 Moberly MO 65270-0306 Ph: (660) 263-6642 | Smile Dental Centralia Llc 110 W Sneed St Centralia MO 65240-1375 Ph: (573) 682-5616 |
| NPI Number | 1033620570 |
|---|---|
| Provider Enumeration Date | 10/23/2017 |
| Last Update Date | 10/23/2017 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033620570 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | (* (Not Available)) | Primary |
News Archive
Children with persistent and drug-resistant seizures treated with the high-fat, low-carbohydrate ketogenic diet may get an added therapeutic benefit from periodic fasting, according to a small Johns Hopkins Children's Center study.
More than a quarter of the hospitals in the Pittsburgh area closed in the first decade of the 21s century, drastically reducing the amount of charitable care available to the poor.
The National Patient Advocate Foundation (NPAF) – a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels – delivered a letter to Dr. William Hazel Jr., M.D., Secretary of Health and Human Resources and Chair of Virginia Governor's Health Information Technology Advisory Commission (HITAC), bringing attention to the need to ensure patients' right to privacy in the state's health information exchange (HIE).
Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. Their discovery, published in the November 12 issue of Nature, lays the foundation for a new kind of therapy aimed directly at a critical human protein — one of a few thousand so-called transcription factors — that could someday be used to treat a variety of diseases, especially multiple types of cancer.
Immune cells known as natural killer (NK) cells are linked with pregnancy problems including pre-eclampsia and recurrent miscarriage. Collaborative research between scientists at the Babraham Institute and Centre for Trophoblast Research in Cambridge is illuminating the role that pregnancy-related NK cells play in moderating the biochemical interactions at the boundary between maternal tissues and the developing foetus.
› Verified 9 days ago